Dr. Eskelund on Study of TP53 Mutations in Mantle Cell Lymphoma
Christian Winther Eskelund, MD
Christian Winther Eskelund, MD, Copenhagen University Hospital, Rigshospitalet, discusses a study of TP53 mutations in mantle cell lymphoma (MCL).
In a study of diagnostic samples from the Nordic trials (MCL2 and MCL3), the analysis showed that TP53 mutations were associated with significantly poorer outcome.
This study aimed to describe the impact and prevalence of TP53 and CDKN2A deletions in young patients with MCL.